Shipment of human islets for transplantation

American Journal of Transplantation

Volumn 7, Issue 4, 2007, Pages 1010-1020

  Ichii, H ^a   Sakuma, Y ^a   Pileggi, A ^a   Fraker, C ^a   Alvarez, A ^a   Montelongo, J ^a   Szust, J ^a   Khan, A ^a   Inverardi, L ^a   Naziruddin, B ^b   Levy, M F ^b   Klintmalm, G B ^b   Goss, J A ^c   Alejandro, R ^a   Ricordi, C ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b BAYLOR HEALTH CARE SYSTEM   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Assessment; Gas permeable bag; Islet consortium; Islet shipment; Islet transplantation

Indexed keywords

PRESERVATION SOLUTION;

ARTICLE; CLINICAL PROTOCOL; GAS PERMEABILITY; ISOLATED PANCREAS ISLET; ISOLATION PROCEDURE; ORGAN PRESERVATION; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; SHIPPING; STORAGE; TRANSPORT MEDIUM;

CELL CULTURE TECHNIQUES; CELL SURVIVAL; HUMANS; ISLETS OF LANGERHANS; ORGAN TRANSPLANTATION; TIME FACTORS; TISSUE AND ORGAN HARVESTING; TISSUE AND ORGAN PROCUREMENT;

EID: 33947599043     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2006.01687.x     Document Type: Article

References (42)

1. Ricordi C, Strom TB. Clinical islet transplantation: Advances and immunological challenges. Nat Rev Immunol 2004; 4: 259-268.
2. Shapiro AM, Lakey JR, Ryan EA et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
3. Hering BJ, Kandaswamy R, Ansite JD et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. JAMA 2005; 293: 830-835.
4. Froud T, Ricordi C, Baidal DA et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 2005; 5: 2037-2046.
5. Markmann JF, Deng S, Huang X et al. Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 2003; 237: 741-750.
6. Goss JA, Schock AP, Brunicardi FC et al. Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 2002; 74: 1761-1766.
7. Goss JA, Goodpastor SE, Brunicardi FC et al. Development of a human pancreatic islet-transplant program through a collaborative relationship with a remote islet-isolation center. Transplantation 2004; 77: 462-466.
8. Rabkin JM, Olyaei AJ, Orloff SL et al. Distant processing of pancreas islets for autotransplantation following total pancreatectomy. Am J Surg 1999; 177: 423-427.
9. Kempf MC, Andres A, Morel P et al. Logistics and transplant coordination activity in the GRAGIL Swiss-French multicenter network of islet transplantation. Transplantation 2005; 79: 1200-1205.
10. Kessler L, Bucher P, Milliat-Guittard L et al. Influence of islet transportation on pancreatic islet allotransplantation in type 1 diabetic patients within the Swiss-French GRAGIL network. Transplantation 2004; 77: 1301-1304.
11. Brunicardi FC, Atiya A, Stock P et al. Clinical islet transplantation experience of the University of California Islet Transplant Consortium. Surgery 1995; 118: 967-971; discussion 971-972.
12. Wahoff DC, Papalois BE, Najarian JS et al. Autologous islet transplantation to prevent diabetes after pancreatic resection. Ann Surg 1995; 222: 562-575; discussion 575-579.
13. Naziruddin B, Khan A, Alejandro R, Ricordi C, Klintmalm G, Levy M. Clinical islet transplantation using remote site processing: Is islet cell culture helpful or harmful? Abstract 8th International Congress of the Cell transplant Society 2006.
14. Yang Z, Chen M, Deng S et al. Assessment of human mpancreatic islets after long distance transportation. Transplant Proc 2004; 36: 1532-1533.
15. Kuroda Y, Kawamura T, Suzuki Y, Fujiwara H, Yamamoto K, Saitoh Y. A new, simple method for cold storage of the pancreas using perfluorochemical. Transplantation 1988; 46: 457-460.
16. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW. Automated method for isolation of human pancreatic islets. Diabetes 1988; 37: 413-420.
17. Lemoli RM, Tafuri A, Strife A, Andreeff M, Clarkson BD, Gulati SC. Proliferation of human hematopoietic progenitors in long-term bone marrow cultures in gas-permeable plastic bags is enhanced by colony-stimulating factors. Exp Hematol 1992; 20: 569-575.
18. Fraker C, Montelongo J, Szust J, Khan A, Ricordi C. The use of multiparametric monitoring during islet cell isolation and culture: A potential tool for in-process corrections of critical physiological factors. Cell Transplant 2004; 13: 497-502.
19. Latif ZA, Noel J, Alejandro R. A simple method of staining fresh and cultured islets. Transplantation 1988; 45: 827-830.
20. Ricordi C, Gray DW, Hering BJ et al. Islet isolation assessment in man and large animals. Acta Diabetol Lat 1990; 27: 185-195.
21. Ranuncoli A, Cautero N, Ricordi C et al. Islet cell transplantation: In vivo and in vitro functional assessment of nonhuman primate pancreatic islets. Cell Transplant 2000; 9: 409-414.
22. London NJ, Contractor H, Lake SP, Aucott GC, Bell PR, James RF. Amicrofluorometric viability assay for isolated human and rat islets of Langerhans. Diabetes Res 1989; 12: 141-149.
23. Ichii H, Pileggi A, Molano RD et al. Rescue purification maximizes the use of human islet preparations for transplantation. Am J Transplant 2005; 5: 21-30.
24. Ichii H, Inverardi L, Pileggi A et al. A novel method for the assessment of cellular composition and beta-cell viability in human islet preparations. Am J Transplant 2005; 5: 1635-1645.
25. Fraker C, Timmins MR, Guarino RD et al. The use of the BD oxygen biosensor system to assess isolated islets of langerhans: Oxygen consumption as a potential measure of islet potency. Cell Transplant 2006; 15: 7452-7458.
26. Ricordi C, Fraker C, Szust J et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 2003; 75: 1524-1527.
27. Ichii H, Wang X, Messinger S et al. Improved human islet isolation using nicotinamide. Am J Transplant 2006; 6: 2060-2068.
28. Rose NL, Palcic MM, Helms LM, Lakey JR. Evaluation of Pefabloc as a serine protease inhibitor during human-islet isolation. Transplantation 2003; 75: 462-466.
29. Matsumoto S, Rigley TH, Reems JA, Kuroda Y, Stevens RB. Improved islet yields from Macaca nemestrina and marginal human pancreata after two-layer method preservation and endogenous trypsin inhibition. Am J Transplant 2003; 3: 53-63.
30. Sawada T, Matsumoto I, Nakano M, Kirchhof N, Sutherland DE, Hering BJ. Improved islet yield and function with ductal injection of University of Wisconsin solution before pancreas preservation. Transplantation 2003; 75: 1965-1969.
31. Tsujimura T, Kuroda Y, Avila JG et al. Influence of pancreas preservation on human islet isolation outcomes: Impact of the two-layer method. Transplantation 2004; 78: 96-100.
32. Linetsky E, Bottino R, Lehmann R, Alejandro R, Inverardi L, Ricordi C. Improved human islet isolation using a new enzyme blend, liberase. Diabetes 1997; 46: 1120-1123.
33. Warnock GL, Meloche RM, Thompson D et al. Improved human pancreatic islet isolation for a prospective cohort study of islet transplantation vs. best medical therapy in type 1 diabetes mellitus. Arch Surg 2005; 140: 735-744.
34. Hering BJ, Kandaswamy R, Harmon JV et al. Transplantation of cultured islets from two-layer preserved pancreases in type 1 diabetes with anti-CD3 antibody. Am J Transplant 2004; 4: 390-401.
35. Ricordi C. Islet transplantation: A brave new world. Diabetes 2003; 52: 1595-1603.
36. Ryan EA, Paty BW, Senior PA et al. Five-year follow-up after clinical islet transplantation. Diabetes 2005; 54: 2060-2069.
37. Nano R, Clissi B, Melzi R et al. Islet isolation for allotransplantation: Variables associated with successful islet yield and graft function. Diabetologia 2005; 48: 906-912.
38. Goto M, Eich TM, Felldin M et al. Refinement of the automated method for human islet isolation and presentation of a closed system for in vitro islet culture. Transplantation 2004; 78: 1367-1375.
39. Ricordi C, Lacy PE, Sterbenz K, Davie JM. Low-temperature culture of human islets or in vivo treatment with L3T4 antibody produces amarked prolongation of islet human-to-mouse xenograft survival. Proc Natl Acad Sci USA 1987; 84: 8080-8084.
40. Stein E, Mullen Y, Benhamou PY et al. Reduction in immunogenicity of human islets by 24 degrees C culture. Transplant Proc 1994;26:755.
41. Lacy PE, Davie JM, Finke EH. Prolongation of islet allograft survival following in vitro culture (24 degrees C) and a single injection of ALS. Science 1979; 204: 312-313.
42. Street CN, Lakey JR, Shapiro AM et al. Islet graft assessment in the Edmonton Protocol: Implications for predicting long-term clinical outcome. Diabetes 2004; 53: 3107-3114.